Research programme: immunotherapeutic vaccines - Scancell

Drug Profile

Research programme: immunotherapeutic vaccines - Scancell

Alternative Names: Modi-1; PAP vaccine - Scancell; PAP-114; SCIB-2; SCMod 1

Latest Information Update: 20 Aug 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Scancell
  • Developer Karolinska Institute; Scancell
  • Class Cancer vaccines; Conjugate-vaccines; DNA vaccines; Immunotherapies; Peptide vaccines; Protein-vaccines
  • Mechanism of Action CD4-positive T lymphocyte stimulants; Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Cancer
  • Research Rheumatoid arthritis
  • Discontinued Infections

Most Recent Events

  • 09 Aug 2018 Scancell expands Moditope® collaboration agreement with Karolinska Institute to develop multiple immunotherapeutic agents for Cancer
  • 03 May 2018 Immunovaccine is now called IMV
  • 03 Apr 2018 Scancell plans a phase I/II trial for Breast cancer (triple negative), Ovarian cancer, and Sarcomas in the first half of 2019
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top